Anne Jokilammi - UTU Research Portal

Anne Jokilammi

- Docent,
- Laboratory Manager
Institute of Biomedicine (Faculty of Medicine)

anjosil@utu.fi

+358 29 450 2310

+358 50 544 3601

Kiinamyllynkatu 10

Turku

ORCID identifier: https://orcid.org/0000-0002-1675-5737

Publications

1 of 3

(2025)
- FEBS Journal
Vaparanta, Katri; Song, Zejia; Farahani, Iman; Jokilammi, Anne; Merilahti, Johannes; Örling, Johanna; Virtanen, Noora; Haapaniemi, Pekka; Sahlgren, Cecilia; Elenius, Klaus; Paatero, Ilkka
(A1 Refereed original research article in a scientific journal)
(2025)
- Molecular Oncology
Ojala, Veera K.; Ahonen, Sini; Peltola, Sara; Tuohisto-kokko, Aura; Esparta, Olaya; Suominen, Peppi; Jokilammi, Anne; Farahani, Iman; Chakroborty, Deepankar; Dibus, Nikol; Boettcher, Steffen; Airenne, Tomi T.; Johnson, Mark S.; Eli, Lisa D.; Elenius, Klaus; Kurppa, Kari J.
(A1 Refereed original research article in a scientific journal)
(2024)
- Biomedicine and PharmacotherapyNature Communications
Huttunen, Roope; Haapanen-Saaristo, Anna-Mari; Hjelt Anja; Jokilammi, Anne; Paatero, Ilkka; Järveläinen, Hannu
(A1 Refereed original research article in a scientific journal)
Immunomodulatory Synthetic Glycocluster Molecule Prevents Melanoma Growth in vivo (2024)
- ChemBioChemMolecular Cancer Therapeutics
Honkanen, Meija; Narvi, Elli; Ojala, Veera; Jokilammi, Anne; Rantakari, Pia; Kronqvist, Pauliina; Kähäri, Veli-Matti; Veräjänkorva, Esko; Kurppa, Kari J; Rahkila, Jani; Ekambaram, Ramesh; Savolainen, Johannes; Leino, Reko; Elenius, Klaus
(A1 Refereed original research article in a scientific journal)
STAT5b is a key effector of NRG-1/ERBB4-mediated myocardial growth (2023)
- EMBO ReportsJournal of Histochemistry and Cytochemistry
Vaparanta Katri, Jokilammi Anne, Paatero Ilkka, Merilahti Johannes A, Heliste Juho, Hemanthakumar Karthik Amudhala, Kivelä Riikka, Alitalo Kari, Taimen Pekka, Elenius Klaus
(A1 Refereed original research article in a scientific journal)
An extracellular receptor tyrosine kinase motif orchestrating intracellular STAT activation (2022)
Vaparanta Katri, Jokilammi Anne, Tamirat Mahlet, Merilahti Johannes AM, Salokas Kari, Varjosalo Markku, Ivaska Johanna, Johnson Mark S, Elenius Klaus
(A1 Refereed original research article in a scientific journal)
Combined genetic and chemical screens indicate protective potential for EGFR inhibition to cardiomyocytes under hypoxia (2021)
- Scientific ReportsBMC Cardiovascular Disorders
Heliste Juho, Jokilammi Anne, Vaparanta Katri, Paatero Ilkka, Elenius Klaus
(A1 Refereed original research article in a scientific journal)
Design of a Cytotoxic Neuroblastoma-Targeting Agent Using an Enzyme Acting on Polysialic Acid Fused to a Toxin (2021)
Lehti Timo A, Pajunen Maria I, Jokilammi Anne, Korja Miikka, Lilie Hauke, Vettenranta Kim, Finne Jukka
(A1 Refereed original research article in a scientific journal)
Decorin Expression in Human Vulva Carcinoma: Oncosuppressive Effect of Decorin cDNA Transduction on Carcinoma Cells (2019)
Marie C. Nyman, Anne B. Jokilammi, Pia C. Boström, Samu H. Kurki, Annele O. Sainio, Seija E. Grenman, Katri J. Orte, Sakari H. Hietanen, Klaus Elenius, Hannu T. Järveläinen
(A1 Refereed original research article in a scientific journal)
Receptor tyrosine kinase profiling of ischemic heart identifies ROR1 as a potential therapeutic target (2018)
Juho Heliste, Anne Jokilammi, Ilkka Paatero, Deepankar Chakroborty, Christoffer Stark, Timo Savunen, Maria Laaksonen, Klaus Elenius
(A1 Refereed original research article in a scientific journal)